wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37232214-B1F8F3F6-CC65-425B-A4C3-3537040EDBE9
Q37232214-B1F8F3F6-CC65-425B-A4C3-3537040EDBE9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37232214-B1F8F3F6-CC65-425B-A4C3-3537040EDBE9
A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration.
P2860
Q37232214-B1F8F3F6-CC65-425B-A4C3-3537040EDBE9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37232214-B1F8F3F6-CC65-425B-A4C3-3537040EDBE9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ccca4eba238634b6be2d19afff0f8f4a83f212bd
P2860
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.